The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Trial Profile

The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 05 Dec 2017

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia
  • Focus Pharmacodynamics
  • Acronyms Cipralex&GBM
  • Most Recent Events

    • 09 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top